Elsevier

Pancreatology

Volume 4, Issue 6, 2004, Pages 561-566
Pancreatology

The role of extended resection in pancreatic adenocarcinoma: Is there good evidence-based justification?

https://doi.org/10.1159/000082181Get rights and content

Abstract

Thus far, there are no studies concerning the radicality of pancreaticoduodenectomy which, in well-performed, randomized-controlled trials employing high standards of evidence-based medicine, show a benefit over extended lymphadenectomy. The results of the only two prospective randomized studies are not comparable and both are underpowered (level of evidence Ib). Therefore, it is still unclear whether extended lymphadenectomy for pancreatic carcinoma improves outcome. Only one study suggests a positive tendency toward increased survival rates in node-positive patients. Extended approaches including additional venous resection can be performed without a rise in the morbidity and mortality rates of patients with pancreatic carcinoma. In the future appropriately powered randomized trials of standard vs. extended resections may show the benefit of extended surgical resections. In addition, well powered trials of postoperative adjuvant therapies or preoperative neoadjuvant strategies together with surgical resections may identify more effective combinations showing a survival benefit in patients with pancreatic carcinoma.

References (36)

  • T Manabe et al.

    Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas

    Cancer

    (1989)
  • K Satake et al.

    Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas

    Surg Gynecol Obstet

    (1992)
  • D Henne-Bruns et al.

    Surgery for ductal adenocarcinoma of the pancreatic head: Staging, complications, and survival after regional versus extended lymphadenectomy

    World J Surg

    (2000)
  • DW McFadden et al.

    Cancer of the pancreas: Radical resection-supporting view

    Adv Surg

    (1994)
  • JG Fortner

    Regional resection of cancer of the pancreas: A new surgical approach

    Surgery

    (1973)
  • JG Fortner et al.

    Regional pancreatectomy. En bloc pancreatic, portal vein and lymph node resection

    Ann Surg

    (1977)
  • JG Fortner et al.

    Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy

    Ann Surg

    (1996)
  • GM Fuhrman et al.

    Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group

    Ann Surg

    (1996)
  • Cited by (25)

    • Pancreatectomy combined with multivisceral resection for pancreatic malignancies: is it justified? Results of a systematic review

      2018, HPB
      Citation Excerpt :

      Complete surgical resection with chemotherapy remains the only potentially curative treatment for pancreatic malignancies.21–23 Centralization of pancreatic surgery and advancement in surgical techniques and perioperative management had led surgeons to consider extended resections.24–29 Only a few studies have evaluated the role of multivisceral resection (MVR) for pancreatic cancer.

    • Pancreatoduodenectomy using a no-touch isolation technique

      2010, American Journal of Surgery
      Citation Excerpt :

      Hence, there is a potential for benefit using a no-touch approach in pancreatectomy as well. A majority of studies confirm the importance of R0 resection, which may only be accomplished with techniques that position the dissecting plane further away from the tumor.5,14–16 By rightward traction of the clamp on the peripancreatic retroperitoneal tissue, nervous and lymphatic tissue on the right and posterior aspects of the SMA can be efficiently cleared.

    • Total pancreatectomy for pancreatic cancer: Indications and operative technique

      2009, HPB
      Citation Excerpt :

      Indications for TP, as perceived by ourselves and others,15–19 are described below. As many patients suffer from local recurrence, tumour resection with negative margins constitutes an important prognostic indicator.20–23 In patients undergoing PP for pancreatic cancer, TP improves survival in isolated neck margin-positive patients and is associated with survival benefit.

    • Portal Vein Resection for Advanced Pancreatic Head Cancer

      2007, Journal of the American College of Surgeons
      Citation Excerpt :

      Many reports have described the outcomes after portal vein resection for pancreatic cancer. Most reports demonstrated that resection and reconstruction of the portal vein can be performed without increased morbidity and mortality.4,11,12 Existing data about longterm survival are less clear.

    View all citing articles on Scopus
    1

    Helmut Friess, MD, Department of General Surgery, University of Heidelberg, Im Neuenheimer Feld 110, DE-69120 Heidelberg (Germany), Tel. +49 6221 56 4860, Fax +49 6221 56 6903

    View full text